Back

Enhanced mTORC1 signaling and Protein Synthesis in Parkinson Disease Pathogenesis

Khan, M. R.; Yin, X.; Kang, S.-u.; Mitra, J.; Wang, H.; Brahmachari, S.; Karuppagounder, S. S.; Kimura, Y.; Jhaldiyal, A.; Kim, H. H.; Gu, H.; Chen, R.; Redding-Ochoa, J.; Troncoso, J.; Ha, T.; Dawson, V. L.; Dawson, T. M.

2022-10-06 neuroscience
10.1101/2022.10.03.510455 bioRxiv
Show abstract

Pathologic -syn destabilizes the TSC 1 and 2 complex leading to mTORC1 activation, enhanced protein translation and neurodegeneration in PD. AbstractPathological -synuclein (-syn) plays an important role in the pathogenesis of -synucleinopathies such as Parkinsons disease (PD). Disruption of protein homeostasis is thought be central to PD pathogenesis, however the molecular mechanism of this deregulation is poorly understood. Here we report that pathologic -syn binds to tuberous sclerosis protein (TSC) 2 and destabilizes the TSC1-TSC2 complex leading to activation of the mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) and enhanced mRNA translation. Dopamine neuron loss, behavioral deficits and aberrant biochemical signaling in the -syn preformed fibril (PFF) and Drosophila -syn transgenic models of pathologic -syn induced degeneration were attenuated by genetic and pharmacologic inhibition of mTOR and protein translation. Our findings establish a potential molecular mechanism by which pathologic -syn activates mTORC1 leading to enhanced protein translation and concomitant neurodegeneration in PD.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.